Home > Financial Ratios > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
Core EBITDA Margin

    Back to All Ratios
SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results

SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 28.6926.2926.4014.7113.78

What is the latest Core EBITDA Margin ratio of SUN PHARMACEUTICAL INDUSTRIES ?

The latest Core EBITDA Margin ratio of SUN PHARMACEUTICAL INDUSTRIES is 28.69 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar202528.69
Mar202426.29
Mar202326.40
Mar202214.71
Mar202113.78

How is Core EBITDA Margin of SUN PHARMACEUTICAL INDUSTRIES Trending?

Years Core EBITDA Margin % Change
Mar2025 28.69
9.13
Mar2024 26.29
-0.42
Mar2023 26.4
79.47
Mar2022 14.71
6.75
Mar2021 13.78 -

Other Financial Ratios of SUN PHARMACEUTICAL INDUSTRIES


Compare Core EBITDA Margin ratio of peers of SUN PHARMACEUTICAL INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES ₹383,564.1 Cr -1.9% -4.1% -6.6% Stock Analytics
DIVIS LABORATORIES ₹162,808.0 Cr -3.6% -12.3% 27.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,734.0 Cr -2.1% 7.2% 9.3% Stock Analytics
CIPLA ₹120,468.0 Cr -0.7% -0% -2.9% Stock Analytics
MANKIND PHARMA ₹104,912.0 Cr -0.8% 0.7% 25.8% Stock Analytics
DR REDDYS LABORATORIES ₹100,212.0 Cr -1.6% -5.4% -12.1% Stock Analytics


SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES

-1.9%

-4.1%

-6.6%

SENSEX

-0.7%

-3.7%

2.4%


You may also like the below Video Courses